A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women

Ai-jun Sun; Ya-ping Wang; Bei Gu; Ting-ping Zheng; Shou-qing Lin; Wen-pei Bai; Yang Wei; Shao-fen Zhang; Ying Zhang

doi:10.1007/s11655-016-2266-y

Your Location：

Home >

Browse articles >

A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women

Updated：2021-08-27

- A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women
- Chinese Journal of Integrative Medicine Vol. 24, Issue 7, Pages: 487-493(2018)
- Affiliations：
  
  1. Department of Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
  2. Department of Obstetrics and Gynecology, Beijing Shijitan Hospital,Beijing,China
  3. Department of Gynecology, Obstetrics and Gynecology, Hospital of Fudan University,Shanghai,China
- Author bio：
- Funds：
  
  Supported by the “Tenth-Five” National Medical Science and Technique Foundation, China (No. 2004BA720A08)
- DOI：10.1007/s11655-016-2266-y
  CLC：
- Published：2018，
  
  Published Online：20 September 2016，
Scan for full text
Sun, Aj., Wang, Yp., Gu, B. et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women., Chin. J. Integr. Med. 24, 487–493 (2018). https://doi.org/10.1007/s11655-016-2266-y

Ai-jun Sun, Ya-ping Wang, Bei Gu, et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women. [J]. Chinese Journal of Integrative Medicine 24(7):487-493(2018)
Sun, Aj., Wang, Yp., Gu, B. et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women., Chin. J. Integr. Med. 24, 487–493 (2018). https://doi.org/10.1007/s11655-016-2266-y DOI：

Ai-jun Sun, Ya-ping Wang, Bei Gu, et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule (和颜坤泰胶囊) and Hormone Therapy in Perimenopausal Women. [J]. Chinese Journal of Integrative Medicine 24(7):487-493(2018) DOI： 10.1007/s11655-016-2266-y.

摘要

To evaluate the efficacy and safety of Heyan Kuntai Capsule (和颜坤泰胶囊

HYKT) and hormone therapy (HT) on perimenopausal syndromes (PMSs). From 2005 to 2008

390 women with PMSs were recruited from 4 clinic centers. The inclusion criteria included ages 40 to 60 years

estradiol (E2) below 30 ng/L

and follicle stimulating hormone (FSH) above 40 IU/L

etc. The patients were randomly assigned to HYKT group or HT group by random number table method

administrated HYKT or conjugated estrogen with/without medroxyprogesterone acetate tablets for 12 months. During treatment

the patients were interviewed quarterly

Kupperman Menopausal Index (KMI) scores

hot flush scores

insomnia scores

Menopause-Specific Quality of Life (MENQOL) scores and adverse effects were used for evaluating drug efficacy and safety respectively. The last interview was made at the end of 12-month treatment After treatment

KMI scores of HYKT group and HT group were both significantly decreased compared with baseline (P <0.01) and there was no significant difference between groups (P >0.05)

except that KMI of HYKT group was higher after 3-month treatment (P <0.05). After treatment

hot flush and insomnia scores were both improved significantly in two groups (P <0.01); and HT had a better performance than HYKT in improving hot flush (P <0.05). MENQOL were significantly improved in both groups after treatment (P <0.01); but there was no significant difference between two groups (P >0.05). The incidence of adverse event in the HYKT group was much lower than that in the HT group (P <0.01). HYKT could effectively relieve PMSs and improve patients quality of life without severe adverse reactions. Although HYKT exerted curative effects more slowly than hormone

it possessed better safety profile than hormone.

Abstract

To evaluate the efficacy and safety of Heyan Kuntai Capsule (和颜坤泰胶囊

HYKT) and hormone therapy (HT) on perimenopausal syndromes (PMSs). From 2005 to 2008

390 women with PMSs were recruited from 4 clinic centers. The inclusion criteria included ages 40 to 60 years

estradiol (E2) below 30 ng/L

and follicle stimulating hormone (FSH) above 40 IU/L

etc. The patients were randomly assigned to HYKT group or HT group by random number table method

administrated HYKT or conjugated estrogen with/without medroxyprogesterone acetate tablets for 12 months. During treatment

the patients were interviewed quarterly

Kupperman Menopausal Index (KMI) scores

hot flush scores

insomnia scores

KMI scores of HYKT group and HT group were both significantly decreased compared with baseline (P <0.01) and there was no significant difference between groups (P >0.05)

except that KMI of HYKT group was higher after 3-month treatment (P <0.05). After treatment

it possessed better safety profile than hormone.

关键词

perimenopausal syndromesHeyan Kuntai Capsulehormone therapyKupperman Menopausal IndexMenopause-Specific Quality of LifeChinese Medicine

Keywords

perimenopausal syndromesHeyan Kuntai Capsulehormone therapyKupperman Menopausal IndexMenopause-Specific Quality of LifeChinese Medicine

references

Liu CM, Sun AJ. Outpatient menopausal women menopause symptoms of anxiety and depression survey. J Reprod Med (Chin) 2007;16:157–160.

Wang SH, Lin SQ, Jin MJ, Gui QF, Chen FL. Efficacies of different low-dose regimens of hormone therapy in postmenopausal women. Chin J Pract Gynecol Obstet (Chin) 2007;23:184–188.

Chen R, Lin SQ, Yang X, Luan YQ, Chen JY, Li DM. Effects of Kuntai Capsule and estradiol valerate on different symptoms of climacteric syndromes. Med Rev (Chin) 2013;19:1869–1872.

Neves-e-Castro M, Birkhauser M, Samsioe G, Lambrinoudaki I, Palacios S, Borrego RS, et al. EMAS position statement: the ten point guide to the integral management of menopausal health. Maturitas 2015;81:88–92.

Cao ZY, ed. The obstetrics and gynecology. Beijing: People’s Medical Publishing House; 1999:2281.

Chen J, Gao H, Li Q, Cong J, Wu J, Pu D, et al. Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis:a randomized study versus tibolone. Med Sci Monit, 2014;20:1950–1957.

Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Subjective insomnia is associated with low sleep efficiency and fatigue in middle-aged women. Climacteric 2016;13:1–9.

Hilditch JR, Lewus J, Peter A, van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161–175.

Yu SY, Liu HL, Miao MS. Molecular mechanism and features of menopausal syndrome treated by Chinese medicine. China J Chin Med (Chin) 2012;27:338–340.

Zhou LF, Guo LY, Yang J, Gao ES, Zhou XP, Zhou GL, et al. Women perimenopausal symptoms and health care demand survey. Matern Child Hlth Care China (Chin) 2006;21:794–796.

The Chinese Medical Association Branch of Obstetrics and Gynaecology Postmenopausal Group. Menopause transition and postmenopausal hormone therapy clinical guidelines revised draft (2006). Chin J Obstet Gyn (Chin) 2008;43:396–398.

Pines A, Sturdee DW, Birkhäuser MH, Schneider HP, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181–194.

Luan YQ, Yang X, Peng XL, Fu C, Meng ZX, Zhang J. Kuntai Capsule treatment of perimenopausal women symptoms of clinical trials randomized double-blind, double simulation parallel. Chin J Clin Pharmacol (Chin) 2004;20:452–455.

Liu XF, Zhang RH, Xu H. Effect of therapy of traditional Chinese medicine five element music and Kuntai Capsule on the depression levels of perimenopausal patients. Matern Child Hlth Care China (Chin) 2010;25:5432–5433.

Shi DG, Sun GZ. Clinical observation of Kuntai Capsule on female menopause insomnia associated with anxiety and depression. Chin Tradit Herb Drugs (Chin) 2013;24:3531–3533.

Chen R, Lin SQ, Yang X, Luan YQ, Chen JY, Chai LN, et al. A randomized, multi-center, double blind and parallel controlled clinical trial for Kuntai Capsule in the treatment of climacteric syndromes. Chin J New Drugs (Chin) 2005;14:1472–1476.

Yang Y. Clinical observation of Kuntai Capsule on perimenopausal symptoms. Tianjin Pharmacol (Chin) 2010;22:34–35.

Wang SH, Lin SQ, Gui QF, Jin MJ, Jiang Y. Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herbs products. J Chin Acad Med Sci (Chin) 2006;28:256–261.

Zhang J, Gong LL, Zhang SF, Chen X, Ji L, Xu Y, et al. Effects of Kuntai Capsule on the quality of life, breast distending pain and vaginal bleeding in women at early stage of menopause. Chin J Integr Tradit west Med (Chin) 2008;28:972–976.

Wang HY, Zhi CC, Zhang CL, Yao KW, Wang J, Huang Y, et al. Effects of Kuntai Capsule on ovarian function and perimenopause symptoms in women with hysterectomy. Med Res Educ (Chin) 2013;30:22–25.

Cheng FR, Wang W. Effects of Kuntai Capsule on the expression of estrogen and its receptor in patients with perimenopausal syndrome. Chin Arch Tradit Chin Med (Chin) 2014;9:2279–2282.

Chen JM, Xu FQ. Clinical analysis of Kuntai Capsule in the treatment of patients with menopausal symptoms and uterine myomas. Chin Remedies Clinics (Chin) 2013;13:511–512.

Li CC, Wang JJ, Chen C, Li YF, Zheng QS, Yang J, et al. Treating menopause syndrome by Kuntai Capsule and hormone replacement therapy: a meta-analysis of efficacy and safety comparison. Chin J Integr Tradit West Med (Chin) 2013;33:1183–1190.

Ji Y, Yuan YX, Xiong XY, Qi JM, Wu W. Effects of Kuntai Capsule on the life quality of climacteric women. J Tradit Chin Med (Chin) 2004;45:206–207.

Zhang QY, Wang JW, Yu JM. Efficacy and safety of Kuntai Capsule and estrogen for menopausal syndrome: a meta-analysis. Chin Med J (Chin) 2013;93:3445–3449.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of Heyan Kuntai Capsule (和颜坤泰胶囊) on Follicular Development and Oocyte Cohesin Levels in Aged Mice

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats

Related Author

No data

Related Institution

Institute of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University

The Academy of Integrative Medicine of Fudan University

Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, the University of Tokyo

Department of Pharmacy, Kepler University Clinic, Neuromed Campus, Linz

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰